The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Share News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: In The Style shares shredded by profit warning

Fri, 24th Sep 2021 11:10

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

Touchstone Exploration Inc, up 30% at 109.00 pence, 12-month range 0.72p-113.95p. The Calgary, Alberta-based upstream oil and gas company says it finished drilling the Royston-1 exploration well, which encountered substantial hydrocarbon accumulations. Says well was drilled to a total depth of 10,700 feet, and mud logging and wireline logs have indicated hydrocarbon accumulations in the Lower Cruse, Karamat and Herrera sections. An aggregate 393 gross feet of hydrocarbon pay was identified in two unique thrust sheets in the Herrera sands from 9,700 feet to total depths. The well is being cased and prepared for production testing at the Herrera formation.

----------

Judges Scientific PLC, up 8.1% at 7,570.00p, 12-month range 4,846.40p-7,600.00p. Shares in the scientific instrument sector investor hit a fresh 12-month high. The firm reports a robust performance in the first half of 2021. For the six months ended June 30, Judges Scientific posts a pretax profit of GBP6.7 million, up 55% from GBP4.3 million in the same period a year before. This was on revenue which grew 15% year-on-year to GBP43.0 million from GBP37.4 million. Judges Scientific remains confident that its performance for 2021 will be ahead of consensus expectations. Declares an interim dividend of 19.0 pence per share, up 15% at 16.5p a year before.

----------

AIM - LOSERS

----------

Argos Resources Ltd, down 18% at 1.13p, 12-month range 1.10p-3.80p. Shares in the Falkland Islands-based exploration firm hit a fresh 12-month low. For the six months ended June 30, loss from operations widened to USD200,000 from USD192,000 as a result of higher administrative costs. During the period, company noted a recovery in the oil industry with a rise in oil prices and increasing activity, but it is still hampered by continued Covid-19 restrictions. In response, Argos requests an extension to the term of licence PL001 to gain more time to recover from the downturn, which was granted to May 1, 2022.

----------

In The Style Group PLC, down 13% at 17.00p, 12-month range 160.00p-264.80p. Shares in e-commerce womenswear fashion brand hit a fresh 12-month low after warning profitability will be hurt by freight and supply chain disruption of recent months. In the Style warns that, despite its attempts to use the most efficient channels whenever possible to ship its products, it expects that higher freight costs and disruption to the timing of shipments are expected to remain for at least the remainder of the current financial year ending March 31, 2022.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
2 Jun 2014 09:13

Imperial Innovation Looks To Raise GBP150.0 Million In Share Placing

LONDON (Alliance News) - Imperial Innovations Group PLC Monday detailed plans to raise up to GBP150.0 million before expenses through a share placing with new and existing investors, as it looks to support its existing portfolio companies, source opportunities to invest in new technologies, and f

Read more
30 May 2014 07:50

Imperial Innovations 44% Owned Veryan Reports Positive Data

LONDON (Alliance News) - Imperial Innovations Group PLC Friday said the third-largest company in its portfolio is set to publish positive new data after a controlled study. In a statement, Imperial Innovations said that Veryan Medical will Friday publish the full two-year data from the Mimi

Read more
22 May 2014 13:08

Imperial Innovations Says JustYoyo Has Completed Investment Round

LONDON (Alliance News) - Imperial Innovations Group PLC Thursday said its portfolio company JustYoyo has completed a GBP2.8 million seed investment round. The investment round for the mobile payments and loyalty company was completing with a second tranche investment, with the first investm

Read more
24 Apr 2014 13:58

Imperial Innovations' Nexeon completes manufacturing facility

Imperial Innovations, the AIM-listed technology group, said that its portfolio company Nexeon has completed the construction and commissioning of its manufacturing facility at its headquarters in Oxfordshire.  Nexeon is Imperial's second-largest portfolio company and develops silicon anode techno

Read more
24 Apr 2014 11:15

Imperial Innovations Says Nexeon Completes Construction Of Headquarters

LONDON (Alliance News) - Imperial Innovations PLC said Thursday its portfolio company Nexeon Ltd has completed the construction and commissioning of its process development and manufacturing facility at its headquarters in Oxfordshire. Nexeon is Innovations' second largest portfolio company

Read more
3 Apr 2014 15:17

DIRECTOR DEALINGS: Imperial Innovations Non-Executive Buys Shares

LONDON (Alliance News) - Imperial Innovations Group PLC Thursday said Non-Executive director David Begg bought 1,470 shares at a price of 403 pence per share. Following this transaction, Begg now holds 21,319 shares, which represents 0.02% stake in the firm. Shares in the software com

Read more
28 Mar 2014 13:14

Imperial Innovations Profit Jumps As Circassia Investment Pays Off

LONDON (Alliance News) - Imperial Innovations Group PLC Friday saw pretax profit rise in the half-year ended January 31, 2014, boosted by the success of its largest investment, Circassia Pharmaceuticals PLC. The technology investment company posted a pretax profit of GBP24.4 million, up fro

Read more
13 Mar 2014 14:22

CORRECTED-UPDATE 2-Allergy drug firm Circassia prices London listing at top of range

(Corrects Reuters Instrument Code to in first paragraph) By Freya Berry LONDON, March 13 (Reuters) - British allergy drug development firm Circassia priced its initial public share offer at the top of its range on Thursday, in the biggest London market debut in years for a biotech com

Read more
13 Mar 2014 08:41

Imperial Innovations' Circassia Prices IPO

LONDON (Alliance News) - Imperial Innovations Group PLC Thursday said its largest portfolio company, Circassia Pharmaceuticals, has successfully priced its IPO on the London Stock Exchange's Main Market. Circassia is expected to raise gross proceeds of about GBP200 million pounds in the pla

Read more
6 Feb 2014 13:55

Imperial Innovations' Circassia to list on LSE main market

Clinical-stage specialty biopharmaceutical company Circassia has announced its intention to float on the London Stock Exchange's Main Market. The company is focused on the development and commercialisation of a range of immunotherapy products for the treatment of allergies, such as those to cats, g

Read more
6 Feb 2014 08:32

UK MORNING BRIEFING: Vodafone Gains, AstraZeneca Falls At Open

LONDON (Alliance News) - Vodafone has delivered results in line with expectations Thursday morning, helping to give UK share a positive start. Vodafone is up 1.4%.

Meanwhile, AstraZeneca has opened down 2.1% after reporting lower revenue and profit

Read more
6 Feb 2014 08:31

UPDATE 1-Circassia seeks $285 mln in bumper UK biotech IPO

* Allergy firm tests European market for larger biotech IPOs * Follows boom in biotech offerings in United States * Funds to help bring cat allergy vaccine to market By Paul Sandle LONDON, Feb 6 (Reuters) - Circassia, a company developing allergy treatments based on a disc

Read more
6 Feb 2014 08:31

UK MORNING BRIEFING:

LONDON (Alliance News) - Vodafone has delivered results in line with expectations Thursday morning, helping to give UK share a positive start. Vodafone is up 1.4%.

Meanwhile, AstraZeneca has opened down 2.1% after reporting lower revenue and profit

Read more
6 Feb 2014 00:01

Allergy drug firm Circassia seeks $285 mln in London IPO

LONDON, Feb 6 (Reuters) - Circassia, a company developing allergy treatments based on a discovery by scientists at Imperial College in London, plans to raise about 175 million pounds ($285 million) of new funds in a stock market debut to bring its cat allergy vaccine to market. Chief execut

Read more
7 Jan 2014 08:22

AIM IN BRIEF: H&T Says Profit As Expected, But Gold Price Has Hurt

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.